EHMA Editorial Influencing EU health policy: supreme discipline or waste of time?

B. Baer
{"title":"EHMA Editorial Influencing EU health policy: supreme discipline or waste of time?","authors":"B. Baer","doi":"10.1179/175330310X12798052449105","DOIUrl":null,"url":null,"abstract":"It is important not to underestimate the importance of the EU for its Member States: it has been estimated that the EU accounts for between 70 per cent and 90 per cent of Member States’ legislation.1 Policies in the field of trade and the single market as well as employment, agriculture and environmental protection all fall under the EU’s competence, and have a strong influence on health. This is in addition to the EU’s remit in health policy itself, where recent developments such as the new draft Directive on Patients Rights in Cross-Border healthcare and the Communication and Council Recommendation on Patient Safety have at least the potential to significantly shape health policy-making at national and local level.2 If the case can be made that the EU is intervening in important policy areas for health managers, it raises the question of how managers, researchers and policy makers can effectively influence its policies. The Brussels landscape is complex, with many different actors and interests, including a specialised cadre of EU lobbyists.3 Recent sources indicate that around 15,000–20,000 lobbyists are currently based in Brussels.4 A similarly large number of training courses are currently offered all around Brussels on lobbying the EU. Although professional lobbyists are an important feature of Brussels politics, this editorial is not focused on them. Rather, the editorial focuses on how those who do not spend their lives immersed in Brussels and its politics — managers, researchers and others — can best engage with the EU and shape health policy at European level. It is often argued that the biggest barrier to influencing the EU is that the EU institutions and Brussels actors are not actually very interested in external views. If one is not part of the Brussels club, there is nothing much that he or she can add. While the argument of democratic deficit is easy to make in relation to the EU, conscious efforts have been made in the last few decades to make the EU more open and transparent.5 It is now generally been accepted that effective EU policy-making needs some form of civil society input.6 In the field of health, stakeholder involvement particularly became a buzz word under Robert Madelin’s leadership of DG SANCO (2003–2010), who created with what he termed ‘co-operative voluntarism’ an alternative to hard legislation, i.e. multi-stakeholder platforms bringing together different interests to encourage them to voluntary agree on and commit to joint guidelines or policies.7 Information on EU health policy initiatives is made available online, and further disseminated by different newsletters and info channels.8 A number of advisory and discussion platforms such as the Health Policy Forum have been set up — often supported by EU funding to cover travel — in an effort to bring stakeholders around the table and promote compromise and legitimacy of EU policies.9 But if the EU is open to hearing and being influenced by stakeholder views, how can managers, researchers and policy makers get involved without having to immediately relocate to Brussels?","PeriodicalId":354315,"journal":{"name":"Journal of Management & Marketing in Healthcare","volume":"34 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2010-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Management & Marketing in Healthcare","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1179/175330310X12798052449105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

It is important not to underestimate the importance of the EU for its Member States: it has been estimated that the EU accounts for between 70 per cent and 90 per cent of Member States’ legislation.1 Policies in the field of trade and the single market as well as employment, agriculture and environmental protection all fall under the EU’s competence, and have a strong influence on health. This is in addition to the EU’s remit in health policy itself, where recent developments such as the new draft Directive on Patients Rights in Cross-Border healthcare and the Communication and Council Recommendation on Patient Safety have at least the potential to significantly shape health policy-making at national and local level.2 If the case can be made that the EU is intervening in important policy areas for health managers, it raises the question of how managers, researchers and policy makers can effectively influence its policies. The Brussels landscape is complex, with many different actors and interests, including a specialised cadre of EU lobbyists.3 Recent sources indicate that around 15,000–20,000 lobbyists are currently based in Brussels.4 A similarly large number of training courses are currently offered all around Brussels on lobbying the EU. Although professional lobbyists are an important feature of Brussels politics, this editorial is not focused on them. Rather, the editorial focuses on how those who do not spend their lives immersed in Brussels and its politics — managers, researchers and others — can best engage with the EU and shape health policy at European level. It is often argued that the biggest barrier to influencing the EU is that the EU institutions and Brussels actors are not actually very interested in external views. If one is not part of the Brussels club, there is nothing much that he or she can add. While the argument of democratic deficit is easy to make in relation to the EU, conscious efforts have been made in the last few decades to make the EU more open and transparent.5 It is now generally been accepted that effective EU policy-making needs some form of civil society input.6 In the field of health, stakeholder involvement particularly became a buzz word under Robert Madelin’s leadership of DG SANCO (2003–2010), who created with what he termed ‘co-operative voluntarism’ an alternative to hard legislation, i.e. multi-stakeholder platforms bringing together different interests to encourage them to voluntary agree on and commit to joint guidelines or policies.7 Information on EU health policy initiatives is made available online, and further disseminated by different newsletters and info channels.8 A number of advisory and discussion platforms such as the Health Policy Forum have been set up — often supported by EU funding to cover travel — in an effort to bring stakeholders around the table and promote compromise and legitimacy of EU policies.9 But if the EU is open to hearing and being influenced by stakeholder views, how can managers, researchers and policy makers get involved without having to immediately relocate to Brussels?
影响欧盟卫生政策:最高纪律还是浪费时间?
重要的是不要低估欧盟对其成员国的重要性:据估计,欧盟占成员国立法的70%至90%贸易和单一市场以及就业、农业和环境保护领域的政策都属于欧盟的职权范围,对健康有很大影响。这是除了欧盟在卫生政策本身的职权范围之外,最近的发展,如新的跨境医疗保健中患者权利指令草案和关于患者安全的沟通和理事会建议,至少有可能在国家和地方一级显著影响卫生政策的制定如果可以证明欧盟正在为卫生管理人员干预重要的政策领域,那么就提出了管理人员、研究人员和决策者如何能够有效地影响其政策的问题。布鲁塞尔的情况是复杂的,有许多不同的参与者和利益,包括一个专门的欧盟游说骨干最近的消息来源表明,目前大约有15,000-20,000名游说者驻扎在布鲁塞尔。目前在布鲁塞尔各地提供的游说欧盟的培训课程也同样大量。尽管专业游说者是布鲁塞尔政治的一个重要特征,但这篇社论并不关注他们。相反,这篇社论关注的是那些不沉浸在布鲁塞尔及其政治中的人——管理人员、研究人员和其他人——如何最好地参与欧盟,并在欧洲层面制定卫生政策。人们常常认为,影响欧盟的最大障碍是,欧盟机构和布鲁塞尔的行动者实际上对外部观点不太感兴趣。如果一个人不是布鲁塞尔俱乐部的一员,他或她就没有什么可以补充的了。虽然关于欧盟的民主赤字的论点很容易提出,但在过去的几十年里,人们已经有意识地努力使欧盟更加开放和透明现在人们普遍认为,有效的欧盟政策制定需要某种形式的民间社会投入7 .在卫生领域,利益攸关方参与在人权和协调委员会总干事Robert Madelin的领导下(2003-2010年)尤其成为一个流行语,他创立了他所称的“合作自愿主义”,作为硬立法的替代方案,即多利益攸关方平台将不同利益相关者聚集在一起,鼓励他们自愿商定并承诺执行联合准则或政策7 .关于欧盟卫生政策倡议的信息在网上提供,并通过不同的通讯和信息渠道进一步传播9 .设立了若干咨询和讨论平台,如卫生政策论坛,这些平台通常由欧盟提供旅费资助,目的是使利益攸关方坐到谈判桌上,促进欧盟政策的妥协和合法性但是,如果欧盟愿意听取利益相关者的意见并受其影响,那么管理者、研究人员和政策制定者如何在不立即搬迁到布鲁塞尔的情况下参与进来呢?
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信